Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature
Néstor López Guerra, Ana Matas-García, Laura Serra‐García, D. Morgado‐Carrasco, Joan Padrosa, Ibán Aldecoa, Yaiza Duque, María Casal-Domínguez, Sandra Muñoz-Braceras, Raquel Aránega, Pedro Moreno, Judith Cantó‐Santos, Glòria Garrabou, Estíbaliz Ruiz‐Ortiz, Ernesto Trallero‐Araguás, Albert Selva-O’Callaghan, Josep M. Grau, Susana Puig, Jiram Torres‐Ruiz, Andrew L. Mammen, Iago Pinal‐Fernandez, José C. Milisenda
Topics & Concepts
MedicinePembrolizumabNivolumabIpilimumabDermatomyositisAutoantibodyInternal medicineImmune checkpointImmune systemOncologyCohortMelanomaImmunologyCancerImmunotherapyAntibodyCancer researchCancer Immunotherapy and BiomarkersInflammatory Myopathies and DermatomyositisCancer Diagnosis and Treatment